ARC and renal cell carcinoma: Silencing ARC significantly promoted TRAIL-induced apoptosis by activating caspase 8 in RCC cells. ARC also suppressed apoptosis by damaging mitochondrial activation. Moreover, silencing ARC remarkably facilitated Topotecan- and ABT-263-induced apoptosis in RCC cells.